首页> 外文期刊>BMC Anesthesiology >The optimum sevoflurane concentration for supraglottic airway device Blockbuster? insertion with spontaneous breathing in obese patients: a prospective observational study
【24h】

The optimum sevoflurane concentration for supraglottic airway device Blockbuster? insertion with spontaneous breathing in obese patients: a prospective observational study

机译:声门上呼吸道装置的最佳七氟醚浓度肥胖患者自发性呼吸插入:一项前瞻性观察研究

获取原文
获取外文期刊封面目录资料

摘要

Airway management of the obese patient presenting for surgery is more likely to be a challenging problem. Supraglottic airway device has been adopted as a bridge to connect ventilation and tracheal intubation in obese patients who would be suffered with difficult intubation. The optimum sevoflurane concentration for supraglottic airway device insertion allowing spontaneous breathing in 50% of obese patients (ED50) is not known. The purpose of this study was to determine the ED50 of sevoflurane for supraglottic airway device Blockbuster? insertion with spontaneous breathing in obese patients requiring general anesthesia. Thirty elective obese patients (body mass index 30-50?kg/m2) undergoing bariatric surgery were recruited in this study. The predetermined target sevoflurane concentration (initiating at 2.5% with 0.5% as a step size) was sustained for >5?min using a modified Dixon’s up-and-down method, and then the supraglottic airway device Blockbuster? was inserted. The patient’s response to supraglottic airway device insertion was classified as either ‘movement’ or ‘no-movement’. The ED50 of sevoflurane were determined by calculating the midpoint concentration of crossover point from ‘movement’ or ‘no-movement’ response. The ED50 of sevoflurane for supraglottic airway device Blockbuster? insertion in obese patients calculated using up-and-down method were 2.50?±?0.60%. The ED50 and ED95 (95% confidence interval) obtained by probit regression analysis were 2.35 (1.28–3.42) % and 4.03 (3.16–17.83) % for supraglottic airway device Blockbuster? insertion, respectively. We conclude that the optimum end-tidal sevoflurane concentration required for the supraglottic airway device Blockbuster? insertion allowing spontaneous breathing in 50% of obese patients (ED50) is 2.5?±?0.6%. Chinese Clinical Trial Registry, ChiCTR-IPR-16009071 , Registered on 24 August 2016.
机译:提出手术的肥胖患者的气道管理更可能是一个具有挑战性的问题。声门上气道装置已被用作连接通气困难和气管插管的肥胖患者的桥梁。尚不知道用于声门上气道设备插入的最佳七氟醚浓度可允许50%的肥胖患者自发呼吸(ED50)。这项研究的目的是确定声门上气道装置“百事达”的七氟醚的ED50。需要全身麻醉的肥胖患者自发插入呼吸。该研究招募了30名接受肥胖症治疗的选择性肥胖患者(体重指数30-50?kg / m2)。使用改良的Dixon上下法,然后使用声门上呼吸道装置“重磅炸弹”,将预定的目标七氟醚浓度(起始浓度为2.5%,起始浓度为0.5%)维持> 5分钟。被插入。患者对声门上气道器械插入的反应分为“运动”或“不运动”。通过从“运动”或“不运动”响应中计算交叉点的中点浓度来确定七氟醚的ED50。声门上气道装置七氟醚的ED50巨大吗?用上下法计算的肥胖患者插入量为2.50%±0.60%。经概率回归分析得出的声门上呼吸道装置“重磅炸弹”的ED50和ED95为2.35(1.28–3.42)%和4.03(3.16–17.83)%。分别插入。我们得出结论,声门上气道装置“百事达克”所需的最佳潮气末七氟醚浓度。在50%的肥胖患者(ED50)中,允许自发呼吸的插入率为2.5%±0.6%。中国临床试验注册中心,ChiCTR-IPR-16009071,2016年8月24日注册。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号